Skip to main content

Advertisement

SpringerLink
Log in

Diagnosis of Acute Leukemia in Cerebrospinal Fluid (CSF-Acute Leukemia)

  • Leukemia (A Aguayo, Section Editor)
  • Published:
Current Oncology Reports Aims and scope Submit manuscript

Abstract

Cerebrospinal fluid-acute leukemia (CSF-acute leukemia) is a frequent and serious complication in patients with acute leukemia. One of the major problems of this complication is the diagnosis process itself. CSF cytology is currently considered the gold standard for establishing the diagnosis, a technique which presents various processing limitations, seriously impacting the predictive values. In the last 11 years, studies of CSF flow cytometry analysis done in patients with acute leukemia have demonstrated superiority in comparison with CSF cytology. Although comparative studies between these two techniques have been reported since 2001, no new consensus or formal changes to the gold standard have been established for the CSF acute leukemia diagnosis. The evidence suggests that positive flow cytometry cases, considered as indeterminate cases, will behave like disease in the central nervous system (CNS). Nevertheless, we think there are some variables and considerations that must be first evaluated under research protocols before CNS relapse can be established with only one positive flow cytometry analysis in the setting of indeterminate CSF samples. This paper proposes a diagnostic algorithm and complementary strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. Clark JL, Perez LM, Jacks LM, Panageas KS, De Angelis LM. Leptomeningeal metastases in the MRI era. Neurology. 2010;74:1449–54.

    Article  Google Scholar 

  2. Karadag D, Karagülle AT, Erden A. Trigeminal nerve involvement in T-cell acute lymphoblastic leukemia: value of MRI imaging. Eur J Radiol. 2002;44:16–8.

    Article  PubMed  Google Scholar 

  3. Eberth C. Zur entwick pung des epitheliomas (cholesteatomas) der pia und der lung. Virchow S Arch. 1870;49:51–63.

    Google Scholar 

  4. •• Wu JM, Georgy MF, Burroughs FH, Weir EG, Rosenthal DL, Ali SZ. Lymphoma, leukemia, and pleocytosis in cerebrospinal fluid: is accurate cytopathologic diagnosis possible based on morphology alone? Diagn Cytopathol. 2009;37:820–4.

    Article  PubMed  Google Scholar 

  5. Prayson R, Fischler D. Cerebrospinal fluid cytology: an 11 year experience with 5951 specimens. Arch Pathol Lab Med. 1998;122:47–51.

    PubMed  CAS  Google Scholar 

  6. Browner WS, Newman TB, Cummings SR. Designing a new study: III. Diagnostic Tests. In: Hulley SB, Cummings SR, editors. Designing clinical research. Williams&Wilkins; 1988. p. 87-97.

  7. Lepoutre V, Jain P, Quann K, Wigfahl B, Khan ZK. Role of resident CNS cell populations in HTLV-1-associated neuroinflammatory disease. Front Biosc. 14:1152-1168.

  8. Jiang L, Abati AD, Wison W, Stetler-Stevenson M, Yuan C. Persistent non-neoplastic γδ-T cells in cerebrospinal fluid of a patient with hepatosplenic (γδ) T cell lymphoma: a case report with 6 years of flow cytometry follow-up. Int J Clin Exp Pathol. 2010;3:110–6.

    CAS  Google Scholar 

  9. Haaxma-Reiche H, Piers A, Beekhuis H. Normal cerebrospinal fluid dynamics. A study with intraventricular injection of 111 In-DTPA in leukemia and lymphoma without meningeal involvement. Arch Neurol. 1989;46:997–9.

    Article  PubMed  CAS  Google Scholar 

  10. Glantz MJ, Cole BF, Glantz LK, Cobb J, Mills P, Lekos A, Walters BC, Recht L. Cerebrospinal fluid cytology in patients with cancer. Minimizing false-negative results. Cancer. 1998;82:733–9.

    Article  PubMed  CAS  Google Scholar 

  11. DuFour MF. Méningite sarcomateuse diffuse avec encahissement de la moelle et des racines: Cytologie positive et special du liquide céphalorachidien. Rev Neurol (Paris). 1904;12:104–6.

    Google Scholar 

  12. McMenemey WH, Cumings JN. The value of the examination of the cerebrospinal fluid in the diagnosis of intracranial tumours. J Clin Pathol. 1959;12:400–11.

    Article  PubMed  CAS  Google Scholar 

  13. Van Wering ER, Veerman AJP, van der Linden-Scherever. Diagnosis of meningeal involvement in childhood acute lymphoblastic leukemia: cytomorphology an TdT. Eur J Haematol. 1988;40:250–5.

    Article  PubMed  Google Scholar 

  14. Bigner SA. Cerebrospinal fluid (CSF) cytology: current Status and diagnostic applications. J Neuropathol Exp Neurol. 1992;51:235–45.

    Article  PubMed  CAS  Google Scholar 

  15. Glass JP, Malamed M, Chernik NL, Posner JB. Malignant cells in cerebrospinal fluid (CSF): the meaning of positive CSF cytology. Neurology. 1979;29:1369–75.

    Article  PubMed  CAS  Google Scholar 

  16. Perske C, Nagel I, Nagel H, Strik H. CSF-cytology the ongoing dilemma to distinguish neoplastic and inflammatory lymphocytes. Diagn Cytopathol. 2011;39:621–6.

    Article  PubMed  Google Scholar 

  17. Manucha V, Zhao F, Rodgers W. Atypical lymphoid cells in cerebrospinal fluid in acute Epstein Barr virus infection. Acta Cytol. 2008;52:334–6.

    Article  PubMed  Google Scholar 

  18. Sato Y, Ohta Y, Honda Y, Oizumi K. Diagnostic value of atypical lymphocytes in cerebrospinal fluid from adults with enteroviral meningitis. J Neurol. 1998;245:598–602.

    Article  PubMed  CAS  Google Scholar 

  19. Cepok S, Jacobsen M, Schock S, Omer B, Jaekel S, Böddeker I, Oertel WH, Sommer N, Hemmer B. Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis. Brain. 2001;124:2169–76.

    Article  PubMed  CAS  Google Scholar 

  20. Schinstine M, Filie A, Wilson W, Stetler-Stevenson M, Abati A. Detection of malignant hematopoietic cells in cerebral spinal fluid previously diagnosed as atypical or suspicious. Cancer Cytopathol. 2006;108:157–62.

    Google Scholar 

  21. Mastrangelo R, Poplack D, Bleyer A, Riccardi R, Sather H, D´Angio G. Report and recommendations of the Rome Workshop concerning poor-prognosis acute lymphoblastic leukemia in children: biologic bases for staging, stratification and treatment. Med Pediatr Oncol. 1986;14:191–4.

    Article  PubMed  CAS  Google Scholar 

  22. Odom LF, Wilson H, Cullen J, Bank J, Blake M, Jamieson B. Significance of blasts in low-cell-count cerebrospinal fluid specimens from children with acute lymphoblastic leukemia. Cancer. 1990;66:1748–54.

    Article  PubMed  CAS  Google Scholar 

  23. Gajjar A, Harrison PL, Sandlund JT, Rivera GK, Ribeiro RC, Rubnitz JE, Razzouk B, Relling MV, Evans WE, Boyett JM, Pui CH. Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia. Blood. 2000;96:3381–4.

    PubMed  CAS  Google Scholar 

  24. Howard SC, Gajjar AJ, Cheng C, Kritchevsky SB, Somes GW, Harrison PL, Ribeiro RC, Rivera GK, Rubnitz JE, Sandlund JT, Armendi AJ, Razzouk BI, Pui CH. Risk factors for traumatic and bloody lumbar puncture in children with acute lymphoblastic leukemia. JAMA. 2002;288:2001–7.

    Article  PubMed  Google Scholar 

  25. Borowitz M, Bigner SH, Johnston WW. Diagnostic problem in the cytologic evaluation of cerebrospinal fluid for lymphoma and leukemia. Acta Cytol. 1981;25:665–74.

    PubMed  CAS  Google Scholar 

  26. Chieng DC, Elgert P, Cohen JM, Jhala NC, Cangiarella JF. Cytology of primary central nervous system neoplasms in cerebrospinal fluid specimens. Diagn Cytopathol. 2002;26:209–12.

    Article  Google Scholar 

  27. Tani E, Costa I, Svedmyr E, Skoog L. Diagnosis of lymphoma, leukemia, and metastatic tumor involvement of the cerebrospinal fluid by cytology and immunocytochemistry. Diagn Cytopathol. 1995;12:14–22.

    Article  PubMed  CAS  Google Scholar 

  28. Chamberlain MC, Glantz M, Groves MD, Wilson WH. Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment. Semin Oncol. 2009;36S2:S35–45.

    Article  Google Scholar 

  29. Nowakowski GS, Call TG, Morice WG, Kurtin PJ, Cook RJ, Zent CS. Clinical significance of monoclonal B cells in cerebrospinal fluid. Clinical cytometry. 2005;63B:23–7.

    Article  Google Scholar 

  30. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW. WHO classification of tumors of haematopoietic and lymphoid tissues. 4th ed. Lyon: Agency for Research on Cancer (IARC); 2008.

  31. Ward MS. The use of flow cytometry in the diagnosis and monitoring of malignant hematological disorders. Pathology. 1999;31:382–92.

    Article  PubMed  CAS  Google Scholar 

  32. •• Subirá D, Castañon S, Román A, Aceituno E, Jiménez-Garófano C, Jiménez A, García R, Bernácer M. Flow cytometry and the study of central nervous disease in patients with acute leukemia. Br J Haematol. 2001;112:381–4.

    Article  PubMed  Google Scholar 

  33. Roma AA, García A, Avagnina A, Rescia C, Elsner B. Lymphoid and myeloid neoplasms involving cerebrospinal fluid: comparison of morphologic examination and immunophenotyping by flow cytometry. Diagn Cytopathol. 2002;27:271–5.

    Article  PubMed  Google Scholar 

  34. Bromberg JEC, Breems DA, Kraan J, Bikker G, van der Holt B, Sillevis Smitt P, van den Bent MJ, van´t Veer M, Gratama JW. CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies. Neurology. 2007;68:1674–9.

    Article  PubMed  CAS  Google Scholar 

  35. Sayed D, Badrawy H, Ali AM, Shaker S. Immunophenotyping and immunoglobulin heavy chain gene rearrangement analysis in cerebrospinal fluid of pediatric patients with acute lymphoblastic leukemia. Leuk Res. 2009;33:655–61.

    Article  PubMed  CAS  Google Scholar 

  36. •• Bommer M, Nagy A, Schöpflin, Pauls S, Ringhoffer M, Schmid M. Cerebrospinal fluid pleocytosis. Pitfalls and benefits of combined analysis using cytomorphology and flow cytometry. Cancer (Cancer Cytopathol). 2011;119:20–6.

    Article  Google Scholar 

  37. Kraan J, Gratama JW, Keeney M, D’Hautcourt JL. Setting up and calibration of a flow cytometer for multicolor immunophenotyping. J Biol Regul Homeost Agents. 2003;17:223–33.

    PubMed  CAS  Google Scholar 

  38. Paul S, Fischer AC, Brambs HJ, Fetscher S, Höche W, Bommer M. Use of magnetic resonance imaging to detect neoplastic meningitis: Limited use in leukemia and lymphoma but convincing results in solid tumors. Eur J Radiol. 2011; [Epub ahead of print].

  39. Kumar R, Nijalingappa S, Grainger J, Ismayl O. Acute disseminated encephalomyelitis mimicking late CNS relapse of acute lymphoblastic leukemia: case report. J Med Case Reports. 2007;1:4.

    Article  Google Scholar 

  40. Hwa Bae S, Mo Ryoo H, Soon Cho H, Lyun Lee J, Hee Lee K, Soo Hyun M. Meningeal relapse in a patient with acute promyelocytic leukemia: a case report and review of the literature. J Korean Med Sci. 2004;19:311–4.

    Article  Google Scholar 

  41. Saiki I, Fujii H, Yoneda J, Abe F, Nakajima M, Tsuruo T, Azuma I. Role of aminopeptidase N (CD13) in tumor-cell invasion and extra-cellular matrix degradation. Int J Cancer. 1993;54:137–43.

    Article  PubMed  CAS  Google Scholar 

  42. Marchetti M, Falanga A, Giovanelli S, Oldani E, Barbui T. All-transretinoic acid increases adhesion to endothelium of the human promyelocytic leukemia cell line NB4. Br J Haematol. 1996;93:360–6.

    Article  PubMed  CAS  Google Scholar 

  43. Dekker AW, Elderson A, Punt K, Sixma JJ. Meningeal involvement in patients with acute nonlymphocytic leukemia. Incidence, management and predictive factors. Cancer. 1985;56:2078–82.

    Article  PubMed  CAS  Google Scholar 

  44. Lipton J, Joffe S, Ullrich NJ. CNS relapse of acute myelogenous leukemia masquerading as pseudotumor cerebri. Pediatr Neurol. 2008;39:355–7.

    Article  PubMed  Google Scholar 

  45. Tiamkao S, Sirijirachai C. Pseudotumor cerebri caused by all-trans-retinoic acid. A case report. J med Assoc Thai. 2000;83:1420–3.

    PubMed  CAS  Google Scholar 

  46. Biojone E, Queiróz R, Valera E, Odashima N, Takayanagui O, Viana M, Gonzaga L, Scrideli C. Minimal residual disease in cerebrospinal fluid at diagnosis: a more intensive treatment protocol was able to eliminate the adverse prognosis in children with acute lymphoblastic leukemia. Leuk Lymphoma. 2012;53:89–95.

    Article  PubMed  CAS  Google Scholar 

  47. Nakayama-Ichiyama S, Yokote T, Hiraoka N, Takayama A, Iwaki K, Kobayashi K, Akioka T, Oka S, Miyoshi T, Takubo T, Tsuji M, Hanafusa T. Central nervous system involvement in adult T-cell lymphoma diagnosed with T-cell receptor gene clonality testing of cerebrospinal fluid. Br J Haematol. 2010;150:629–32.

    Article  PubMed  Google Scholar 

  48. Januszkiewicz DA, Nowak JS. Molecular evidence for central nervous system involvement in children with newly diagnosed acute lymphoblastic leukemia. Hematol Oncol. 1995;13:201–6.

    Article  PubMed  CAS  Google Scholar 

  49. Pine SR, Yin C, Matloub YH, Sabaawy HE, Sandoval C, Lenedoglu-Tugal O, Ozkaynak MF, Jayabose S. Detectioin of central nervous system leukemia in children with acute lymphoblastic leukemia by real-time polymerase chain reaction. J Mol Diagn. 2005;7:127–32.

    Article  PubMed  CAS  Google Scholar 

  50. Nuñez CA, Zipf TF, Roberts WM, Medeiros LJ, Bueso-Ramos CE. Molecular monitoring of cerebrospinal fluid can predict clinical relapse in acute lymphoblastic leukemia with eosinophilia. Arch Pathol Lab Med. 2003 May;127:601–5.

    PubMed  Google Scholar 

  51. Wasserman R, Felix CA, McKenzie SE, Shane S, Lange B, Finger LR. Identification of an altered immunoglobulin heavy-chain gene rearrangement in the central nervous system in B-precursor acute lymphoblastic leukemia. Leukemia. 1993;7:1294–9.

    PubMed  CAS  Google Scholar 

  52. Harigae H, Kobayashi M, Mihara A, Watanabe N. Detection of minimal residual disease in cerebro-spinal fluid of a patient with acute Myelogenous leukemia with t(16;21) 8p11;q22) translocation by reverse transcriptase-polymerase chain reaction. Tohoku J Exp Med. 1997;183:297–302.

    Article  PubMed  CAS  Google Scholar 

  53. Crivii SM, Neamtu S, Bocsan G. Neuroimmunitary profile estimation in cerebrospinal fluid and its importance in childhood acute lymphoblastic leukemia. Arch Gescwulstforsch. 1989;59:199–204.

    CAS  Google Scholar 

  54. Musto P, Tomasi P, Cascavilla N, Ladogana S, La Sala A, Melillo L, Nobile M, Castoldi G, Carotenuto M. Significance and limits of cerebrospinal fluid beta-2 microglobulin measurement in course of acute lymphoblastic leukemia. Am J Hematol. 1988;28:213–8.

    Article  PubMed  CAS  Google Scholar 

  55. Storti S, Pagano L, Marra R, Teofili L, Ricerca BM, Leone G, Bizzi B. Cerebrospinal fluid beta-2-microglobulin: a reliable index of leukemic infiltration of central nervous system. Scand J Haematol. 1986;37:301–5.

    PubMed  CAS  Google Scholar 

  56. Pudek MR, Chan KW, Rogers PC, Teasdale JM. Beta 2-microglobulin levels in cerebrospinal fluid of children with leukemia and lymphoma. Clin Biochem. 1985;18:180–3.

    Article  PubMed  CAS  Google Scholar 

  57. Mavlight GM, Stuckey SE, Cabanillas FF, Keating MJ, Tourtellotte WW, Schold SC, Freireich EJ. Diagnosis of leukemia or lymphoma in the central nervous system by beta 2-microglobulin determination. N Eng J Med. 1980;25:718–22.

    Article  Google Scholar 

  58. Oberg G, Hälgren R, Venge P. Beta 2-microglobulin, lysozyme and lactoferrin in cerebrospinal fluid in patients with lymphoma or leukemia: relationship to CNS involvement and the effect of prophylactic intrathecal treatment with methotrexate. Br J Haematol. 1987;66:315–22.

    Article  PubMed  CAS  Google Scholar 

  59. Nagelkerke AF, van Kamp GJ, Veerman AJ, de Waal FC. Unreliability of beta-2-microglobulin in early detection of central nervous system relapse in acute lymphoblastic leukemia. Eur J Cancer Clin Oncol. 1985;21:659–63.

    Article  PubMed  CAS  Google Scholar 

  60. Bürger B, Zimmermann M, Mann G, Kühl J, Löning L, Riehm H, Reiter A, Schrappe M. Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture. J Clin Oncol. 2003;21:184–8.

    Article  PubMed  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Clínica de Leucemia Aguda, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México

    Erick Crespo-Solis

  2. Departamento de Hematología y Oncologia, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México

    Xavier López-Karpovitch

  3. Departamento de Radiología e Imagen, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México

    Jesús Higuera

  4. Departamento of Ciencias Morfológicas de la Facultad de Medicina de la Universidad Autónoma de Yucatán, Mérida, Yucatán, México

    Beatriz Vega-Ramos

Authors
  1. Erick Crespo-Solis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xavier López-Karpovitch
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jesús Higuera
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Beatriz Vega-Ramos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Erick Crespo-Solis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Crespo-Solis, E., López-Karpovitch, X., Higuera, J. et al. Diagnosis of Acute Leukemia in Cerebrospinal Fluid (CSF-Acute Leukemia). Curr Oncol Rep 14, 369–378 (2012). https://doi.org/10.1007/s11912-012-0248-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11912-012-0248-6

Keywords

Search

Navigation